Former Franchise Group chief executive Brian Kahn has pleaded guilty to participating in a years-long scheme that defrauded hedge fund investors of roughly $300m, a scandal that ultimately helped bring down both Prophecy Asset Management and FRG, according to a
Blockstream Capital Partners is expanding its institutional investment platform with the acquisition of Corbiere Capital Management, a Jersey-based equities and event-driven hedge fund firm founded by former BlueCrest CIO Rodrigo Rodriguez.
Ilex Capital Partners, the equity long-short multi-manager launched in London by former Citadel traders Jonas Diedrich and Dave Sutton, has grown to around $7bn in assets following a fresh capital raise and continued performance gains, according to a report by
New hedge fund launches are on the increase across Dubai and Abu Dhabi, as Senior Portfolio Managers from global multi-strats set up their own ventures – with many backed not by local sovereign wealth, but by major allocators in the
Hedge fund investors holding Brightline’s $1.1bn corporate debt are preparing a restructuring plan that could give them priority over other creditors while providing new financing to the struggling high-speed rail project, according to a report by Bloomberg.
Global short sellers continued to focus on consumer and Software & Services sectors in November, according to Hazeltree’s latest Shortside Crowdedness Report, which tracks anonymised data from over 600 asset managers globally.
London-based systematic digital asset manager Temple Capital, which manages around $120m in assets, has joined the collateral mirroring programme offered by digital asset exchange OKX in partnership with Standard Chartered.
Hedge fund firm Point72’s quant arm, Cubist Systematic Strategies, has seen another senior departure as Jae Ho Kim, head of portfolio research, has gone on gardening leave, according to a report by eFinancial Careers.
Hedge funds with heavy exposure to biotech, including Perceptive Advisors, have posted some of the industry’s strongest returns in 2025, fuelled by a surge in large-cap pharma M&A and the sector’s sharpest rally in a decade, according to a report
Warner Bros shares climbed sharply this week as event-driven hedge funds ramped up positions in anticipation of a bidding war between Paramount and Netflix, with merger arbitrage managers suggesting that at least one bidder is likely to raise its offer,
